J. P. Bowen

发表

O. Güner, Nne E Uko, D. Matesic, 2020, Current topics in medicinal chemistry.

Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors.

G. McGaughey, J. P. Bowen, C. Cavallito, 2004, Journal of molecular graphics & modelling.

Molecular Mechanics (MM3) Calculations on Oxygen-Containing Phosphorus (Coordination IV) Compounds.

N. L. Allinger, J. P. Bowen, E. L. Stewart, 1999, The Journal of organic chemistry.

Xylanase homology modeling using the inverse protein folding approach

J. P. Bowen, D. Whitmire, X. Chen, 1996, Protein science : a publication of the Protein Society.

Molecular mechanics (MM2) parameters for divinyl ethers and aromatic halide derivatives

N. L. Allinger, J. P. Bowen, D. Patterson, 1988 .

Differential formation of nitrogen-centered radicals leading to unprecedented, regioselective bromination of N,N′-(1,2-phenylene)bisamides and 2-amidophenols

J. P. Bowen, F. Fronczek, E. B. Watkins, 2020 .

Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis.

P. Silver, P. Cohen, B. Perry, 2007, Blood.

angiogenesis a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling ) , is Solenopsis invicta Solenopsin , the alkaloidal component of the fire ant

P. Silver, P. Cohen, B. Perry, 2006 .

Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors

T. Duarte, C. Spencer, J. P. Bowen, 2019, Medicinal Chemistry Research.

Molecular design and clinical development of VEGFR kinase inhibitors.

J. P. Bowen, Haizhen A. Zhong, J. Bowen, 2007, Current topics in medicinal chemistry.

Ab Initio and Molecular Mechanics Calculations on the Inversion of Cs to C2 Conformations of 1,3-Cycloheptadiene

N. L. Allinger, J. P. Bowen, E. Stewart, 1994 .

Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues.

Adrienne E. Scott, Tiffany T. Howard, Luanne M. McNulty, 2002, Bioorganic & medicinal chemistry.

Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors.

O. Güner, Nne E Uko, D. Matesic, 2018, Bioorganic & medicinal chemistry letters.

Density functional and Ab initio studies on N-acetylduocarmycin SA: insight into its DNA interaction properties.

R. C. Stanley, J. P. Bowen, K. Kirschner, 2000, Bioorganic & medicinal chemistry.

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition

J. P. Bowen, R. Phillips, Emma Carine Iradukunda, 2019, Front. Mol. Biosci..

Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii.

O. Güner, J. P. Bowen, R. Phillips, 2017, Bioorganic & medicinal chemistry letters.

Torsional effects in glycoside reactivity: saccharide couplings mediated by acetal protecting groups

C. W. Andrews, J. P. Bowen, E. Skowronski, 1991 .

Molecular mechanics (MM4) force field development for phosphine and its alkyl derivatives.

J. P. Bowen, G. Liang, P. Todebush, 2002, Chirality.

Molecular mechanics (MM3) parameterization for oxocarbenium ions

J. P. Bowen, D. Whitmire, G. Liang, 2000, J. Comput. Chem..

Crystal and molecular structure of augustamine

E. M. Holt, B. S. Joshi, J. P. Bowen, 2000 .

Molecular mechanics studies of acyl halides: I. Molecular structures and conformational analysis

J. P. Bowen, J. Shim, J. Bowen, 1998, J. Comput. Chem..

A portrait of the chemist: The Lou Allinger story

J. P. Bowen, J. Bowen, 1998 .

Ab initio calculations and molecular mechanics (MM3) force field development for sulfonamide and its alkyl derivatives

J. P. Bowen, G. Liang, J. Bays, 1997 .

Molecular mechanics (MM3) studies of monochloroalkanes

N. L. Allinger, J. P. Bowen, J. Shim, 1997 .

Towards a Better Understanding of Computational Models for Predicting DNA Methylation Effects at the Molecular Level.

J. P. Bowen, E. Taylor, N. Chiu, 2020, Current topics in medicinal chemistry.

Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.

J P Bowen, R. Mailman, P. Charifson, 1988, Journal of medicinal chemistry.

An ab initio study (6-31G*) of transition states in glycoside hydrolysis based on axial and equatorial 2-methoxytetrahydropyrans

J. Phillip Bowen, C. Webster Andrews, C. W. Andrews, 1991 .

Molecular mechanical investigations of the properties of oxocarbenium ions. 1. Parameter development

C. W. Andrews, R. Woods, J. P. Bowen, 1992 .

Molecular mechanical investigations of the properties of oxocarbenium ions. 2. Application to glycoside hydrolysis

C. W. Andrews, R. Woods, J. P. Bowen, 1992 .

Synthesis and biological evaluation of aromatic enones related to curcumin.

J. Arbiser, J. P. Bowen, T. Robinson, 2005, Bioorganic & medicinal chemistry.

AN EFFICIENT SYNTHESIS OF 2-ARYL AND 2-ALKENYL-3-ALKOXY-CYCLOHEXENONES BY A MODIFIED STILLE REACTION

J. P. Bowen, T. Robinson, D. Goldsmith, 1999 .

Solenopsin A and analogs exhibit ceramide-like biological activity

J. Arbiser, Jin Zhang, J. P. Bowen, 2015, Vascular cell.

Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.

J. Arbiser, J. P. Bowen, Xianhe Bai, 2003, Bioorganic & medicinal chemistry letters.

Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.

J P Bowen, R. Mailman, P. Charifson, 1989, Journal of medicinal chemistry.

Theoretical study of stereoselective reduction controlled by NADH analogs.

J. P. Bowen, Haizhen A. Zhong, 2005, Journal of molecular graphics & modelling.

Molecular modeling studies of some choline acetyltransferase inhibitors.

G. McGaughey, J. P. Bowen, M. Kontoyianni, 1994, Journal of medicinal chemistry.

Molecular mechanics studies of ketene derivatives and related structures

J. P. Bowen, E. Stewart, 1992 .

Recent advances in small molecule inhibitors of VEGFR and EGFR signaling pathways.

J. P. Bowen, Haizhen A. Zhong, J. Bowen, 2011, Current topics in medicinal chemistry.

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors

O. Güner, J. P. Bowen, R. Phillips, 2022, Molecules.

Ab initio and molecular mechanics (MM2 and MM3) calculations of nonconjugated positively charged nitrogen‐containing compounds

J. Phillip Bowen, Eugene L. Stewart, Georgia B. McGaughey, 1995, J. Comput. Chem..

Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides.

Carly A. Price, Erik C. Madsen, J. Hartley, 2002, Bioorganic & medicinal chemistry letters.

Computer‐Assisted Molecular Modeling: Indispensable Tools for Molecular Pharmacology

Dora Schnur, Maria Kontoyianni, Peter C. Fox, 1993, Journal of clinical pharmacology.

Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

O. Güner, K. Griendling, David I. Brown, 2017, Bioorganic & medicinal chemistry.

Antiangiogenic agents: studies on fumagillin and curcumin analogs.

J. Arbiser, J. P. Bowen, T. Robinson, 2005, Current pharmaceutical design.

THEORETICAL INVESTIGATION OF THE CA+-N2 AND CA2+-N2 COMPLEXES

B. Ma, J. P. Bowen, K. Kirschner, 1998 .

Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.

J Phillip Bowen, J. P. Bowen, Haizhen Zhong, 2006, Current medicinal chemistry.

Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors.

J. Arbiser, J. P. Bowen, Haizhen A. Zhong, 2013, Current pharmaceutical design.

The impact of ionization States of matrix metalloproteinase inhibitors on docking-based inhibitor design.

J Phillip Bowen, J. Arbiser, J. P. Bowen, 2011, ACS medicinal chemistry letters.

Setting the Record Straight: The Origin of the Pharmacophore Concept

Osman F. Güner, J. Phillip Bowen, O. Güner, 2014, J. Chem. Inf. Model..

Antitumor agents. 113. New 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.

D. Schnur, Y. Cheng, J. P. Bowen, 1990, Journal of medicinal chemistry.

Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine

O. Güner, Nne E Uko, D. Matesic, 2019, AntiCancer Research.

Comparative molecular field analysis and molecular modeling studies of 20-(S)- camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents

Peter C. Fox, Sean W. Carrigan, S W Carrigan, 1997, J. Comput. Aided Mol. Des..

Ab initio and molecular mechanics (MM3) calculations on alkyl‐ and arylboronic acids

J. P. Bowen, D. Whitmire, G. Liang, 1998 .

Solenopsin A, a venom alkaloid from the fire ant Solenopsis invicta, inhibits quorum-sensing signaling in Pseudomonas aeruginosa.

J. Arbiser, K. Janda, J. P. Bowen, 2008, The Journal of infectious diseases.

Computational studies on electron transfer by the iminium metabolite of phencyclidine (PCP)

J. P. Bowen, P. Kovacic, C. Dyke, 2000 .

Molecular mechanics treatment of .beta.-heteroatom-substituted cyclohexanones

N. L. Allinger, J. P. Bowen, 1987 .

Computational modeling of a putative fetal alcohol syndrome mechanism.

J. P. Bowen, J. Shim, P. Whitmire, 1995, Alcoholism, clinical and experimental research.

AB INITIO AND MOLECULAR MECHANICS (MM3) CALCULATIONS ON PROPARGYL ALCOHOL AND DERIVATIVES

J. P. Bowen, E. Stewart, U. Mazurek, 1996 .

[10]Annulene: The Wealth of Energetically Low-Lying Structural Isomers of the Same (CH)10 Connectivity

H. Schaefer, J. P. Bowen, Yaoming Xie, 1994 .

Molecular Mechanics: The Art and Science of Parameterization

J. Phillip Bowen, Norman L. Allinger, N. L. Allinger, 2007 .

The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo

J. P. Bowen, K. Rice, N. Moniri, 2019, Pharmacology Biochemistry and Behavior.

Pharmacophore modeling for ADME.

J. P. Bowen, O. Guner, J. Bowen, 2013, Current topics in medicinal chemistry.

Hartree−Fock and Møller−Plesset (MP2) Treatment of Oxygen-Containing Phosphorus Compounds

J. P. Bowen, E. Stewart, N. Nevins, 1997 .

Perspectives in Medicinal Chemistry: The Evolution of Medicinal Chemistry.

J. P. Bowen, Haizhen A. Zhong, 2015, Current topics in medicinal chemistry.

Parameter analysis and refinement toolkit system and its application in MM3 parameterization for phosphine and its derivatives

J. Phillip Bowen, Peter C. Fox, Guyan Liang, 1996, J. Comput. Chem..

Ab initio calculations with electronic correlation (MP2) on the nucleic acid bases and their methyl derivatives

N. L. Allinger, J. P. Bowen, E. Stewart, 1994 .